Normal cognitive behavior in two distinct congenic lines of transgenic mice hyperexpressing mutant APPSWE

Neurobiology of Disease

Volumn 12, Issue 3, 2003, Pages 194-211

  Savonenko, Alena V ^a,b   Xu, Guilian M ^b   Price, Donald L ^b   Borchelt, David R ^b   Markowska, Alicja L ^a,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Aging; Cross sectional; Longitudinal; Memory; Place discrimination; Water maze; Amyloid

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

AGE; AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACKCROSSING; COGNITION; CONCENTRATION (PARAMETERS); CONGENIC STRAIN; DISEASE MODEL; FAMILIAL DISEASE; FEMALE; GLIA; MALE; MEMORY DISORDER; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PSYCHOPHYSIOLOGY; TASK PERFORMANCE; TRANSGENIC MOUSE; WORKING MEMORY;

EID: 0038755949     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-9961(02)00012-8     Document Type: Article

References (44)

1. Andreasson K.I., Savonenko A.V., Vidensky S., Goellner J.J., Zhang Y., Shaffer A., Kaufmann W.I., Worley P.F., Isakson P., Markowska A.L. Age-dependent cognitive deficits and neuronal loss cyclooxygenase-2 transgenic mice. J. Neurosci. 21:2001;8198-8209.
2. Mutant mice and neuroscience recommendations concerning genetic background . Neuron. 19:1997;755-759.
3. Borchelt D.R., Davis J., Fischer M., Lee M.K., Slunt H.H., Ratovitsky T., Regard J., Copeland N.G., Jenkins N.A., Sisodia S.S., Price D.L. A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet. Anal. (Biomed. Eng.). 13:1996;159-163.
4. Borchelt D.R., Ratovitski T., Van Lare J., Lee M.K., Gonzales V.B., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Accelerated amyloid deposition in the brains of transgenic mice co-expressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 19:1997;939-945.
5. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C., Glabe C. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267:1992;546-554.
6. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., Younkin L., Good M.A., Bliss T.V.P., Hyman B.T., Younkin S.G., Hsiao K.K. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nature Neurosci. 2:1999;271-276.
7. Crawley J., Balknap J., Collins A., Crabbe J., Frankel W., Henderson N., Hitzemann R., Maxson S., Miner L., Silva A., Wehner J., Wynshaw-Boris A., Paylor R. Behavioral phenotypes of inbred mouse strains implications and recommendations for molecular studies . Psychopharmacology. 132:1997;107-124.
8. Dewachter I., van Dorple J., Spittaels K., Tesseur I., Van den Haute C., Moechars D., Van Leuven F. Modeling Alzheimer's disease in transgenic mice effect of age and presenilin 1 on amyloid biochemistry and pathology in APP/London mice . Exp. Gerontol. 35:2000;831-841.
9. Dodart J.C., Mathis C., Bales K.R., Paul S.M., Ungerer A. Behavioral deficits in APP(V717F) transgenic mice deficient for the apolipoprotein E gene. Neuroreport. 11:2000;603-607.
10. Dodart J.C., Meziane H., Mathis C., Bales K.R., Paul S.M., Ungerer A. Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Behav. Neurosci. 113:1999;982-990.
11. Fanselow M.S. Opiate modulation of the active and inactive components of the postshock reaction parallels between naloxone pretreatment and shock intensity . Behav. Neurosci. 98:1984;269-277.
12. Flood J.F., Morley P.M., Morley J.E. Age-related changes in learning, memory, and lipofuscin as a function of the percentage of SAMP8 genes. Physiol. Behav. 58:1995;819-822.
13. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Scubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527.
14. Holcomb L.A., Gordon M.N., Jantzen P., Hsiao K., Duff K., Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations lack of association with amyloid deposits . Behav. Genet. 29:1999;177-185.
15. Hsia A.Y., Masliah E., McConlogue L., Yu G.Q., Tatsuno G., Hu K., Kholodenko D., Malenka R.C., Nicoll R.A., Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA. 96:1999;3228-3233.
16. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficts, Aβ elevation and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
17. Iwatsubo T., Mann D.M.A., Odaka A., Suzuki N., Ihara Y. Amyloid β protein (Aβ) deposition Aβ42(43) preceds Aβ40 in Down syndrome . Ann. Neurol. 37:1995;294-299.
18. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of Aβ42(43)-positive and Aβ40-positive senile plaques with end-specific Aβ-monoclonal antibodies evidence that an initially deposited Aβ species is Aβ1-42(43) . Neuron. 13:1994;45-53.
19. Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D., Chishti M.A., Horne P., Heslin D., French J., Mount H.T.J., Nixon R.A., Mercken M., Bergeron C., Fraser P.E., St George-Hyslop P., Westaway D. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 408:2000;979-982.
20. Jarrett J.T., Lansbury P.T. Jr. Seeding "one-dimensional crystallization" of amyloid a pathogenic mechanism in Alzheimer's disease and scrapie? Cell. 73:1993;1055-1058.
21. 42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. USA. 94:1997;1550-1555.
22. Kammesheidt, A., Boyce, F.M., Spanoyannis, A.F., Cummings, B.J., Ortegón, M., Cotman, C., Vaught, J.L., Neve, R.L., 1992. Deposition of β/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyterminal fragment of the Alzheimer amyloid precursor in the brain. Proc. Natl. Acad. Sci. USA 10857-10861.
23. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London). 227:1970;680-685.
24. Lemere C.A., Blusztajn J.K., Yamaguchi H., Wisniewski T., Saido T.C., Selkoe D.J. Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome implications for initial events in amyloid plaque formation . Neurobiol. Dis. 3:1996;16-32.
25. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185.
26. Logue S.F., Owen E.H., Rasmussen D.L., Wehner J.M. Assessment of locomotor activity, acoustic and tactile startle, and prepulse inhibition of startle in inbred mouse strains and F1 hybrids implications of genetic background for single gene and quantitative trait loci analyses . Neuroscience. 80:1997;1075-1086.
27. Markowska A.L. Sex dimorphisms in the rate of age-related decline in spatial memory relevance to alterations in the estrous cycle . J. Neurosci. 19:1999;8122-8133.
28. Markowska A.L., Long J.M., Johnson C.T., Olton D.S. Variable-interval probe test as a tool for repeated measurements of spatial memory in the water maze. Behav. Neurosci. 107:1993;627-632.
29. Markowska A.L., Spangler E.L., Ingram D.K. Behavioral assessment of the senescence-accelerated mouse (SAM P8 and R1). Physiol. Behav. 64:1998;15-26.
30. McCullagh P., Nelder J.A. Generalized Linear Models. 1989;Chapman and Hall, London.
31. Moechars D., Dewachter I., Lorent K., Reverse D., Baekelandt V., Naidu A., Tesseur I., Spittaels K., Haute C.V., Checler F., Godaux E., Cordell B., Van Leuven F. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274:1999;6483-6492.
32. Moechars D., Lorent K., De Strooper B., Dewachter I., Van Leuven F. Expression in brain of amyloid precursor protein mutated in the α-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J. 15:1996;1265-1274.
33. Moran P.M., Higgins L.S., Cordell B., Moser P.C. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human β-amyloid precursor protein. Proc. Natl. Acad. Sci. USA. 92:1995;5341-5345.
34. Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J., Duff K., Jantzen P., DiCarlo G., Wilcock D., Connor K., Hatcher J., Hope C., Gordon M., Arendash G.W. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 408:2000;982-985.
35. Morris J.C. Diagnosis of Alzheimer's disease. Khachaturian Z.S., Radebaugh T.S. Alzheimer's Disease Cause(s), Diagnosis, Treatment, and Care . 1996;75-84 CRC Press, Boca Raton.
36. Nalbantoglu J., Tirado-Santiago G., Lahsaïni A., Poirier J., Goncalves O., Verg G., Momoli F., Welner S.A., Massicotte G., Julien J.-P., Shapiro M.L. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature. 387:1997;500-505.
37. Olton D.S. The radial arm maze as a tool in behavioral pharmacology. Physiol. Behav. 40:1987;793-797.
38. Oster-Granite M.L., McPhie D.L., Greenan J., Neve R.L. Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. J. Neurosci. 16:1996;6732-6741.
39. Owen E.H., Logue S.F., Rasmussen D.L., Wehner J.M. Assessment of learning by the Morris water task and fear conditioning in inbred mouse strains and F1 hybrids implications of genetic background for single gene mutations and quantitative trait loci analyses . Neuroscience. 80:1997;1087-1099.
40. Raber J., Wong D., Yu G.Q., Buttini M., Mahley R.W., Pitas R.E., Mucke L. Apolipoprotein E and cognitive performance. Nature. 404:2000;352-353.
41. Rodgers R.J., Cole J.C. Influence of social isolation, gender, strain, and prior novelty on plus-maze behaviour in mice. Physiol. Behav. 54:1993;729-736.
42. Selkoe D.J. Alzheimer's disease a central role for amyloid . J. Neuropathol. Exp. Neurol. 53:1994;438-447.
43. Stone W.S., Walser B., Gold S.D., Gold P.E. Scopolamine- and morphine-induced impairments of spontaneous alteration performance in mice reversal with glucose and with cholinergic and adrenergic agonists . Behav. Neurosci. 105:1991;264-271.
44. Wyss-Coray T., Masliah E., Mallory M., McConlogue L., Johnson-Wood K., Lin C., Mucke L. Amyloidogenic role of cytokine TGF-á1 in transgenic mice and in Alzheimer's disease. Nature. 389:1997;603-606.